Revance Therapeutics, Inc. RVNC was a big mover last session, as its shares rose nearly 26% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company as the stock is now trading above the volatile price range of $26.16 to $33.70 in the past one-month timeframe.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Revance Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include TrovaGene, Inc. TROV, ZIOPHARM Oncology, Inc. ZIOP and Biogen Idec Inc. BIIB. All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BIOGEN IDEC INC BIIB: Free Stock Analysis Report
REVANCE THERAP RVNC: Free Stock Analysis Report
TROVAGENE INC TROV: Get Free Report
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Revance Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include TrovaGene, Inc. TROV, ZIOPHARM Oncology, Inc. ZIOP and Biogen Idec Inc. BIIB. All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BIOGEN IDEC INC BIIB: Free Stock Analysis Report
REVANCE THERAP RVNC: Free Stock Analysis Report
TROVAGENE INC TROV: Get Free Report
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
